Bank of America’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,734
| Closed | -$1K | – | 7738 |
|
|
2019
Q3 | $1K | Hold |
1,734
| – | – | ﹤0.01% | 7214 |
|
|
2019
Q2 | $1K | Sell |
1,734
-2,127
| -55% | -$1.53K | ﹤0.01% | 7131 |
|
|
2019
Q1 | $4K | Hold |
3,861
| – | – | ﹤0.01% | 6844 |
|
|
2018
Q4 | $2K | Hold |
3,861
| – | – | ﹤0.01% | 6936 |
|
|
2018
Q3 | $6K | Sell |
3,861
-6,000
| -61% | -$7.97K | ﹤0.01% | 6805 |
|
|
2018
Q2 | $3K | Hold |
9,861
| – | – | ﹤0.01% | 6890 |
|
|
2018
Q1 | $3K | Hold |
9,861
| – | – | ﹤0.01% | 6875 |
|
|
2017
Q4 | $9K | Sell |
9,861
-7
| -0.1% | -$8 | ﹤0.01% | 6648 |
|
|
2017
Q3 | $15K | Buy |
9,868
+137
| +1% | +$167 | ﹤0.01% | 6407 |
|
|
2017
Q2 | $12K | Sell |
9,731
-10,500
| -52% | -$12K | ﹤0.01% | 6394 |
|
|
2017
Q1 | $22K | Hold |
20,231
| – | – | ﹤0.01% | 6288 |
|
|
2016
Q4 | $21K | Sell |
20,231
-30
| -0.1% | -$34 | ﹤0.01% | 6334 |
|
|
2016
Q3 | $21K | Buy |
20,261
+20
| +0.1% | +$24 | ﹤0.01% | 6119 |
|
|
2016
Q2 | $29K | Sell |
20,241
-2,896
| -13% | -$3.73K | ﹤0.01% | 6098 |
|
|
2016
Q1 | $30K | Buy |
23,137
+120
| +0.5% | +$161 | ﹤0.01% | 5986 |
|
|
2015
Q4 | $28K | Buy |
23,017
+20
| +0.1% | +$27 | ﹤0.01% | 6305 |
|
|
2015
Q3 | $37K | Sell |
22,997
-32
| -0.1% | -$62 | ﹤0.01% | 6087 |
|
|
2015
Q2 | $48K | Buy |
23,029
+666
| +3% | +$1.71K | ﹤0.01% | 5962 |
|
|
2015
Q1 | $66K | Sell |
22,363
-75
| -0.3% | -$238 | ﹤0.01% | 5532 |
|
|
2014
Q4 | $71K | Buy |
22,438
+17,936
| +398% | +$60.5K | ﹤0.01% | 6133 |
|
|
2014
Q3 | $15K | Buy |
4,502
+596
| +15% | +$1.74K | ﹤0.01% | 7195 |
|
|
2014
Q2 | $10K | Hold |
3,906
| – | – | ﹤0.01% | 7482 |
|
|
2014
Q1 | $11K | Buy |
3,906
+2,315
| +146% | +$7K | ﹤0.01% | 7179 |
|
|
2013
Q4 | $4K | Sell |
1,591
-250
| -14% | -$701 | ﹤0.01% | 7559 |
|
|
2013
Q3 | $14K | Buy |
1,841
+1,543
| +518% | +$11.9K | ﹤0.01% | 7063 |
|
|
2013
Q2 | $2K | Buy |
+298
| New | +$2.16K | ﹤0.01% | 7559 |
|
Bank of America's CELGZ Position: Q4 2019 in Review
Bank of America sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 1,734 shares — an estimated $1K sold.
Bank of America first reported a position in CELGZ in Q2 2013 and held it in 26 quarters. The position peaked at $71K in Q4 2014. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.
- Bank of America reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 1,734 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $1K.
- Bank of America first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 26 quarters.
- Bank of America's Celgene Corporation Contingent Value Rights position peaked at $71K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.